PCI Timing in ACS

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”>


CHAPTER 25 PCI TIMING IN ACS


Early Invasive vs. Selectively Invasive Management for Acute Coronary Syndromes


de Winter RJ, Windhausen F, Cornel JH, et al. N Engl J Med. 2005;353:1095–1104


BACKGROUND


Acute Coronary Syndromes (ACS) is a leading cause of mortality and morbidity in the United States and Percutaneous Coronary Intervention (PCI) has been a revolutionary advancement in the treatment of ACS. At the time of this study, guidelines recommend early PCI for patients with ACS without ST-segment elevation and troponinemia; however, clinical trials at the time only provided mixed support for this recommendation due to varied results, different definitions of myocardial infarction, inadequate study methods, and a failure to include other advancements in diagnostic testing and medical therapy such as low-molecular-weight heparins, dual antiplatelet therapy, and high-dose statins.


OBJECTIVES


To test the hypothesis that a general early invasive strategy is superior to a selectively invasive strategy for patients with ACS without ST-segment elevation and/or with an elevated troponin Unstable angina/Non-ST segment elevated myocardial infarction (UA/NSTEMI).


METHODS


Prospective, multicenter randomized control study at 42 Dutch hospitals between 2001 and 2003.


Patients

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on PCI Timing in ACS

Full access? Get Clinical Tree

Get Clinical Tree app for offline access